Of all the firms Shanghai Pharma is seeking to buy into — the list also includes U.S. specialty drugmaker Arbor Pharmaceuticals LLC and Alvogen Inc.’s North American business– winning Cardinal’s distribution arm makes the most sense. It would hand …
( read original story …)